Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Frontiers in Immunology|February 20, 2014
Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T CellsRosa Bacchetta, Barbarella Lucarelli, Claudia Sartirana, et al.
Clinical Immunology (Orlando, Fla.)|February 19, 2013
Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunityKevin Goudy, Didem Aydin, Federica Barzaghi, et al.
The Journal of Allergy and Clinical Immunology|December 25, 2019
Treatment with rapamycin can restore regulatory T-cell function in IPEX patientsLaura Passerini, Federica Barzaghi, Rosalia Curto, et al.
Science Translational Medicine|December 20, 2023
Identification of unstable regulatory and autoreactive effector T cells that are expanded in patients with <i>FOXP3</i> mutationsŠimon Borna, Esmond Lee, Jason Nideffer, et al.
Science Translational Medicine|September 11, 2015
Hurdles in therapy with regulatory T cellsPiotr Trzonkowski, Rosa Bacchetta, Manuela Battaglia, et al.
Science Translational Medicine|October 27, 2021
Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patientsPauline P Chen, Alma-Martina Cepika, Rajni Agarwal-Hashmi, et al.
Clinical Immunology (Orlando, Fla.)|February 8, 2011
Clinical heterogeneity and diagnostic delay of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndromeCinzia Mazza, Fabio Buzi, Federica Ortolani, et al.
The Journal of Allergy and Clinical Immunology|September 24, 2022
Epigenetic and immunological indicators of IPEX disease in subjects with FOXP3 gene mutationMansi Narula, Uma Lakshmanan, Simon Borna, et al.
Pageof 11